ACE Report Cover
Addition of Rifampin to Antimicrobial Therapy Does Not Improve Success Rate in Staphylococcal PJI
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
GENERAL ORTHOPAEDICS
Addition of Rifampin to Antimicrobial Therapy Does Not Improve Success Rate in Staphylococcal PJI .
Verified
This report has been verified by one or more authors of the original publication.

Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial.

J Orthop Surg Res. 2020; 15: 365.

Sixty-five patients with staphylococcal peri-prosthetic joint infections of the hip or knee were randomized to receive debridement and wound excision plus 6 weeks of antimicrobial therapy (intravenous cloxacillin or vancomycin), with or without the addition of oral rifampin. The outcome of interest was treatment success at 2 years follow up, defined as a lack of clinical signs of peri-prosthetic joint infection, C-reactive protein levels < 10mg/mL, erythrocyte sedimentation rate as prior to index operation, and no radiological signs of loosening. No significant difference in treatment success rate was observed between the rifampin and control groups at 2 years post-treatment. Moreover in the sub-group analysis by bacteria type (Staphylococcus aureus; Coagulase-negative staphylococci), no significant differences in treatment success rate were observed between the two groups.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Addition of Rifampin to Antimicrobial Therapy Does Not Improve Success Rate in Staphylococcal PJI. ACE Report. 2020;9(9):19. Available from: https://myorthoevidence.com/AceReport/Show/addition-of-rifampin-to-antimicrobial-therapy-does-not-improve-success-rate-in-staphylococcal-pji

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report